GD, R., N, W., R, Y., S, C., M, A., & K, W. (2024). Intravenous Versus Oral Omadacycline or Linezolid for Acute Bacterial Skin and Skin Infections: A post hoc Analysis of the OASIS Trials. Infectious diseases and therapy, 13(12), 2637. https://doi.org/10.1007/s40121-024-01057-3
Chicago Style (17th ed.) CitationGD, Rodriguez, Warren N, Yashayev R, Chitra S, Amodio-Groton M, and Wright K. "Intravenous Versus Oral Omadacycline or Linezolid for Acute Bacterial Skin and Skin Infections: A Post Hoc Analysis of the OASIS Trials." Infectious Diseases and Therapy 13, no. 12 (2024): 2637. https://doi.org/10.1007/s40121-024-01057-3.
MLA (9th ed.) CitationGD, Rodriguez, et al. "Intravenous Versus Oral Omadacycline or Linezolid for Acute Bacterial Skin and Skin Infections: A Post Hoc Analysis of the OASIS Trials." Infectious Diseases and Therapy, vol. 13, no. 12, 2024, p. 2637, https://doi.org/10.1007/s40121-024-01057-3.